In vivo, intracerebral administration of GDF5 confers neuroprotective and neurorestorative effects on the adult rat nigrostriatal pathway in 6-hydroxydopamine (6-OHDA)-lesioned adult rat models of PD [25–27]. Here, GDF5 is linked to Parkinson disease.